has been cited by the following article(s):
|
[1]
|
The synthesis and antineoplastic activities of thiaziridine, sulfidometylphosphonium, and dithiaphosphitane‐sulfide against the Ehrlich ascites carcinoma
|
|
Fundamental & …,
2022 |
|
|
|
|
[2]
|
N-Substituted Aryl Sulphonamides as Potential Anti-Alzheimer's Agents: Design, Synthesis and Biological Evaluation
|
|
Current Computer - Aided Drug Design,
2018 |
|
|
|
|
[3]
|
In Silico Evaluation of Inhibitory Potential of Sulfonamide Derivatives against Diadenosine Tetraphosphate Hydrolase as Antimalarial Agents
|
|
2017 |
|
|
|
|
[4]
|
N-(2-methyl-indol-1H-5-yl)-1-naphthalenesulfonamide: A novel reversible antimitotic agent inhibiting cancer cell motility
|
|
Biochemical Pharmacology,
2016 |
|
|
|
|
[5]
|
Protective and Curative Effect of Thymoquinone on Ehrlich Solid Carcinoma Inoculated Mice.
|
|
2015 |
|
|
|
|
[6]
|
Protective and Curative Effect of Thymoquinone on Ehrlich Solid Carcinoma Inoculated Mice
|
|
Egyptian Journal of Hospital Medicine (Jan. 2015),
2015 |
|
|
|
|
[7]
|
Combined inhibition of AKT/mTOR and MDM2 enhances Glioblastoma Multiforme cell apoptosis and differentiation of cancer stem cells
|
|
Scientific reports,
2015 |
|
|
|
|
[8]
|
In vitro antimitotic, antiproliferative and DNA fragmentation assay of ethanol extract of Carmona retusa (Vahl.) Masam
|
|
Applied Cell Biology,
2013 |
|
|
|
|
[1]
|
The synthesis and antineoplastic activities of thiaziridine, sulfidometylphosphonium, and dithiaphosphitane‐sulfide against the Ehrlich ascites carcinoma
Fundamental & Clinical Pharmacology,
2022
DOI:10.1111/fcp.12751
|
|
|
|
|
[2]
|
N-(2-methyl-indol-1H-5-yl)-1-naphthalenesulfonamide: A novel reversible antimitotic agent inhibiting cancer cell motility
Biochemical Pharmacology,
2016
DOI:10.1016/j.bcp.2016.06.016
|
|
|
|
|
[3]
|
Combined inhibition of AKT/mTOR and MDM2 enhances Glioblastoma Multiforme cell apoptosis and differentiation of cancer stem cells
Scientific Reports,
2015
DOI:10.1038/srep09956
|
|
|
|
|
[4]
|
Combined inhibition of AKT/mTOR and MDM2 enhances Glioblastoma Multiforme cell apoptosis and differentiation of cancer stem cells
Scientific Reports,
2015
DOI:10.1038/srep09956
|
|
|
|